Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Jack

Showing results (421-430 of 594) with videos related to

Pageof 60
Sort By:
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
JAMA Oncology|December 27, 2019
Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysisJianchun Duan, Longgang Cui, Xiaochen Zhao, et al.
Journal of the National Cancer Institute|February 6, 2003
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trialJonathan M Kurie, Reuben Lotan, J Jack Lee, et al.
Clinical Lung Cancer|October 4, 2018
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable AlterationsVincent K Lam, Hai T Tran, Kimberly C Banks, et al.
Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 14, 2024
Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry AnalysisBrady J Anderson, Amy C Moreno, Yun Qing, et al.
The American Journal of Pathology|June 19, 2016
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical ActivityMarina Cardó-Vila, Serena Marchiò, Masanori Sato, et al.
Plos Neglected Tropical Diseases|June 9, 2018
Epidemiology and risk factors for typhoid fever in Central Division, Fiji, 2014-2017: A case-control studyNamrata Prasad, Aaron P Jenkins, Lanieta Naucukidi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2022
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast CancerParijatham S Thomas, Anisha B Patel, J Jack Lee, et al.
Pageof 60

Showing results (421-430 of 594) with videos related to

Sort By:
Pageof 60
Molecular Cancer Therapeutics|July 22, 2017
JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung CancerKazuhiko Shien, Vassiliki A Papadimitrakopoulou, Dennis Ruder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
JAMA Oncology|December 27, 2019
Use of Immunotherapy With Programmed Cell Death 1 vs Programmed Cell Death Ligand 1 Inhibitors in Patients With Cancer: A Systematic Review and Meta-analysisJianchun Duan, Longgang Cui, Xiaochen Zhao, et al.
Journal of the National Cancer Institute|February 6, 2003
Treatment of former smokers with 9-cis-retinoic acid reverses loss of retinoic acid receptor-beta expression in the bronchial epithelium: results from a randomized placebo-controlled trialJonathan M Kurie, Reuben Lotan, J Jack Lee, et al.
Clinical Lung Cancer|October 4, 2018
Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable AlterationsVincent K Lam, Hai T Tran, Kimberly C Banks, et al.
Clinical Lung Cancer|April 14, 2020
Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant ChemotherapyAnnikka Weissferdt, Apar Pataer, Ara A Vaporciyan, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 14, 2024
Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry AnalysisBrady J Anderson, Amy C Moreno, Yun Qing, et al.
The American Journal of Pathology|June 19, 2016
Interleukin-11 Receptor Is a Candidate Target for Ligand-Directed Therapy in Lung Cancer: Analysis of Clinical Samples and BMTP-11 Preclinical ActivityMarina Cardó-Vila, Serena Marchiò, Masanori Sato, et al.
Plos Neglected Tropical Diseases|June 9, 2018
Epidemiology and risk factors for typhoid fever in Central Division, Fiji, 2014-2017: A case-control studyNamrata Prasad, Aaron P Jenkins, Lanieta Naucukidi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2022
Phase I Dose Escalation Study of Topical Bexarotene in Women at High Risk for Breast CancerParijatham S Thomas, Anisha B Patel, J Jack Lee, et al.
Pageof 60